Closed · W81XWH-09-BCRP-IMPT · CFDA 12.420 · Discretionary
DoD Breast Cancer Impact Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- June 17, 2009
- Close date
- 5
- Expected awards
The verdict
DoD Breast Cancer Impact Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 5 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 5
- expected awards
- 12.420
- CFDA program
Archived opportunity record
DoD Breast Cancer Impact Award is closed (last close June 17, 2009). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed June 17, 2009
Est. Total Funding
$17,000,000
Expected Awards
5
Instrument
Grant
Description
The Impact Award supports unique research projects or ideas (from small- to large-scale) that specifically focus on scientific and clinical breast cancer issues, which, if successfully addressed, could ultimately revolutionize the understanding and/or treatment of breast cancer and move closer to the goal of eradicating the disease. The critical components of this award mechanism are as follows: Impact: The most important aspect of the Impact Award is the potential of the proposed research to have a radical, revolutionary impact on an area of paramount importance in breast cancer. The research project may be basic, translational, or clinical. The potential impact may be near-term or long-term, but it must be transformative. It is the responsibility of the applicant to clearly and explicitly articulate the potential impact on breast cancer, including how it would be transformative. Research Question: Research proposed under the Impact Award must address an underexplored issue of critical significance in breast cancer. The BCRP particularly encourages applications that focus on less explored or poorly understood areas that are of high importance in breast cancer, such as those related to prevention, susceptibility, protection, recurrence, and metastasis. The proposed work must be based on a sound overall research strategy and may be from any discipline or combination of disciplines (from all areas of basic, translational, clinical, behavioral, and epidemiological research). Applications submitted under the Impact Award mechanism should not meet the intent of the other award mechanisms offered by the BCRP in FY09. NEW for FY09: A preproposal is required as part of the pre-application; application submission is by invitation only.
Catch-all / unrestricted eligibility mark · W81XWH-09-BCRP-IMPT
Grants.gov marks DoD Breast Cancer Impact Award with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
DoD Breast Cancer Impact Award is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |